) and scientific software company, BioDiscovery Inc., together
launched an analysis software solution for cancer research - Nexus
Nexus Copy Number is an advanced discovery tool for interrogating
large data sets, specifically tailored for analyzing data generated
by Affymetrix's genetic analysis platforms including CytoScan
Cytogenetics Suite and OncoScan FFPE Assay Kit.
CytoScan Cytogenetics Suite and OncoScan FFPE Assay Kit are key
genetic analysis platforms in Affymetrix's cancer research
The CytoScan platform is used extensively for research on
hematological cancer -- Nexus Copy Number for Affymetrix has a set
of tools that help uncover key genomic events in these projects.
The newly-launched software retains all the analytical tools from
BioDiscovery's flagship Nexus Copy Number product, however, it is
exclusively designed to support Affymetrix's arrays only. Its
algorithms and statistical methods allow easy translation of raw
data into meaningful results.
The data from Affymetrix assays perform well with the Nexus
software for detecting copy number variants (CNVs) from different
cancer samples. To date, researchers have found CNVs (a form of
structural variation or alteration of the DNA of a genome) and copy
neutral changes in liquid and solid tumor samples.
With the use of the Nexus Copy Number, researchers can further
identify biomarkers that drive disease progression and gain
additional insight into cancer biology.
Affymetrix's last reported quarter witnessed strong growth in the
Genetic Analysis segment, which includes revenues from both
cytogenetics and genotyping product lines. The company is extremely
optimistic about the future of its OncoScan FFPE Assay Kit and is
steadily altering OncoScan from a service to a product offering.
Currently Affymetrix carries a Zacks Rank #2 (Buy). Other
well-performing players in the healthcare industry include
ANI Pharmaceuticals, Inc.
Gilead Sciences Inc.
). All these stocks sport a Zacks Rank #1(Strong Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
ILLUMINA INC (ILMN): Free Stock Analysis Report
GILEAD SCIENCES (GILD): Free Stock Analysis
AFFYMETRIX INC (AFFX): Free Stock Analysis
ANI PHARMACEUT (ANIP): Free Stock Analysis
To read this article on Zacks.com click here.